跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tuftsin
首页
药物
Tuftsin
Tuftsin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHOSPHORYLCHOLINE-TUFTSIN CONJUGATE FOR TREATING OCULAR INFLAMMATION
US 20250375529 A1
申请人: TARSIER PHARMA LTD
优先权: 2017
CN
US
2 件公开
LIQUID COMPOSITIONS COMPRISING A PHOSPHORYLCHOLINE-TUFTSIN CONJUGATE
EP 4433488 A4
申请人: TARSIER PHARMA LTD
优先权: 2021
EP
US
2 件公开
PATIENT SELECTION FOR OCULAR TREATMENT
EP 4753688 A1
申请人: TARSIER PHARMA LTD
优先权: 2023
EP
WO
2 件公开
Peptides for enhancing resistance to microbial infections
US 2005143293 A1
申请人: KORPELA TIMO K
优先权: 2002
US
2 件公开
Tuftsin metallopeptide analogs and uses thereof
US 7097824 B2
申请人: PALATIN TECHNOLOGIES INC
优先权: 2003
US
2 件公开
USE OF A TUFTSIN AS A THERAPEUTIC AGENT
US 2010210567 A1
申请人: BEVEC DORIAN
优先权: 2007
US
A liquid-phase synthesis method of tuftsin
CN 101550180 A
申请人: HANGZHOU HUAJIN PHARMACEUTICAL
优先权: 2009
CN
Branched polypeptide using immune active peptide as vector and derivatives and application of branched polypeptide
CN 102153654 B
申请人: INST VIRAL DISEASE CONTROL & PREVENTION CHINESE CT DISEASE CONTROL & PREVENTION
优先权: 2009
CN
COMPOSITIONS AND METHODS FOR LEUKOCYTE-TARGETING MULTI-VALENT IMAGING PROBES
US 2013144035 A1
申请人: PAN DONGFENG
优先权: 2011
US
Anti-tumor fusion protein as well as encoding gene and application thereof
CN 104151432 A
申请人: INST MED BIOTECHNOLOGY CAMS
优先权: 2013
CN
第 1 / 3 页
上一页
下一页
药物
反馈